TotalEnergies sells half of French wind and solar portfolio to Eiffel Investment Group

Patrick Pouyanné Chairman and Chief Executive Officer TotalEnergies SE
Patrick Pouyanné Chairman and Chief Executive Officer - TotalEnergies SE
0Comments

TotalEnergies has completed the sale of a 50% stake in a 270 megawatt wind and solar energy portfolio in France to investment funds managed by Eiffel Investment Group. The deal values the portfolio at €265 million. After this transaction, TotalEnergies will keep a 50% share and continue operating the assets, handling most of their electricity production and sales.

The company’s business model for renewables involves selling up to half of its renewable assets once they begin commercial operation and are considered low risk. This approach aims to maximize asset value while managing risks as part of its integrated power strategy, which combines renewables like solar and wind with flexible assets such as gas-fired plants and storage.

Eiffel Investment Group manages around €7 billion in assets, according to data from June 2025. Its investors include large institutions and retail clients. The firm focuses on financing energy transition projects through various strategies including private debt, equity, and listed investments. Eiffel employs about 110 professionals across offices in Europe, the United States, and the UAE.

As of June 2025, TotalEnergies reported more than 30 gigawatts of installed gross renewable electricity capacity worldwide and has set targets to reach 35 GW by year-end and over 100 terawatt-hours of net electricity production by 2030.

TotalEnergies operates globally in oil, natural gas, biofuels, biogas, hydrogen, renewables, and electricity. With more than 100,000 employees in about 120 countries, it places sustainability at the center of its strategy.

###



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.